BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34284421)

  • 1. Metastatic Uterine Carcinosarcoma to the Orbit.
    Qureshi S; Patel NA; Patel N; Ghassibi MP; Tse DT; Dubovy SR
    Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):e198-e202. PubMed ID: 34284421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis between uterine carcinosarcoma versus carcinoma with sarcomatous metaplasia: an immunohistochemical and ultrastructural case study.
    Raspollini MR; Taddei GL; Marchionni M; Bacci S; Romagnoli P
    Ultrastruct Pathol; 2005; 29(2):149-55. PubMed ID: 16028671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
    Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
    Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uterine carcinosarcoma in a teenager: report of a case macroscopically mimicking rhabdomyosarcoma].
    Rouas L; Regragui A; Oukabli M; Amrani M; Gamra L; Otmani A; Bellabas MA
    Rev Med Liege; 2005 Dec; 60(12):911-4. PubMed ID: 16457389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual Cutaneous Metastasis of Uterine Carcinosarcoma: A Case Report and Review of the Literature.
    Clairwood M; Yasuda M; Belazarian L; Deng A
    Am J Dermatopathol; 2016 May; 38(5):366-9. PubMed ID: 26675357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus.
    Hoskins PJ; Le N
    Int J Gynecol Cancer; 2008; 18(6):1200-1. PubMed ID: 18217961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinosarcoma of the corpus uteri (Malignant Müllerian Mixed Tumor): a case report in Yaoundé (Cameroon).
    Sando Z; Fouelifack FY; Fouogue JT; Fouedjio JH; Anoudem CE; Nangue C
    Pan Afr Med J; 2013; 16():145. PubMed ID: 24876903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review literature on uterine carcinosarcoma.
    Singh R
    J Cancer Res Ther; 2014; 10(3):461-8. PubMed ID: 25313723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yolk Sac Tumor Arising in Uterine Carcinosarcoma With Endometrioid and Serous Components: A Case Report With Immunohistochemical Analysis.
    Grindstaff S; Hanley LC; Banet N
    Int J Gynecol Pathol; 2022 Jan; 41(1):40-44. PubMed ID: 33770060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?
    McCluggage WG
    J Clin Pathol; 2002 May; 55(5):321-5. PubMed ID: 11986333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinosarcoma (malignant mixed müllerian tumor) of the uterus with a rhabdoid tumor component. An immunohistochemical, ultrastructural, and immunoelectron microscopic case study.
    Mount SL; Lee KR; Taatjes DJ
    Am J Clin Pathol; 1995 Feb; 103(2):235-9. PubMed ID: 7856569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.
    Pinto A; Mackrides N; Nadji M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine carcinosarcoma. Case report.
    Germano A; Stellato G; Botti G; Lombardo G; De Simone A; Iodice F
    Eur J Gynaecol Oncol; 1989; 10(6):411-6. PubMed ID: 2627972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status.
    da Silva JL; de Albuquerque LZ; Rodrigues FR; Bastos NC; Small IA; Barroso EBC; Cordero FL; Fernandes DS; Paulino E; de Melo AC
    PLoS One; 2023; 18(5):e0285447. PubMed ID: 37200263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
    Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
    Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinosarcoma of the uterus in a woman with Down syndrome.
    Al-Badawi IA; AlOmar O; Kornfeld I
    Hematol Oncol Stem Cell Ther; 2010; 3(3):161-2. PubMed ID: 20890074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solitary fibrous tumor of the orbit.
    Ing EB; Kennerdell JS; Olson PR; Ogino S; Rothfus WE
    Ophthalmic Plast Reconstr Surg; 1998 Jan; 14(1):57-61. PubMed ID: 9513245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 12 cases of uterine carcinosarcoma].
    Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L
    Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.